Haralampos Moutsopoulos

Haralampos Moutsopoulos's AcademicInfluence.com Rankings

Philosophy

#3673

World Rank

#5889

Historical Rank

Logic

#1321

World Rank

#2042

Historical Rank

philosophy Degrees

Haralampos Moutsopoulos

Biology

#4631

World Rank

#6884

Historical Rank

Immunology

#203

World Rank

#212

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Haralampos Moutsopoulos Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Haralampos Moutsopoulos's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group (2002) (4954)
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. (1993) (1533)
Increased risk of lymphoma in sicca syndrome. (1978) (985)
The risk of lymphoma development in autoimmune diseases: a meta-analysis. (2005) (679)
Clinical manifestations and early diagnosis of Sjögren syndrome. (2004) (615)
Sjögren's syndrome (Sicca syndrome): current issues. (1980) (499)
Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. (2008) (498)
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. (1996) (483)
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. (2000) (473)
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. (2002) (453)
Mortality in systemic sclerosis: an international meta-analysis of individual patient data. (2005) (435)
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. (2005) (419)
Sjögren's syndrome: autoimmune epithelitis. (1994) (386)
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. (1994) (352)
EuropeanStudy Group on Classification Criteria for Sjögren's Syndrome. Classificationcriteria for Sjögren's syndrome: a revised version of the European criteriaproposed by the American-European Consensus Group (2002) (342)
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. (2010) (339)
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. (1987) (339)
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. (2008) (305)
The geoepidemiology of Sjögren's syndrome. (2010) (272)
Sjögren’s Syndrome or Autoimmune Epithelitis? (2007) (265)
Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome: Clinical and Pathophysiologic Aspects (2009) (244)
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. (1996) (242)
Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. (2004) (212)
Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. (2007) (206)
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. (2004) (205)
Sjögren-type syndrome after allogeneic bone-marrow transplantation. (1977) (198)
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. (2007) (196)
Clinically Significant and Biopsy‐Documented Renal Involvement in Primary Sjogren Syndrome (2000) (193)
Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. (1977) (192)
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. (2007) (192)
Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. (1979) (192)
The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren’s syndrome (2002) (191)
Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. (2005) (190)
Pathogenesis of Sjögren's syndrome: what we know and what we should learn. (2012) (189)
Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease (1999) (188)
Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. (1995) (188)
Prevalence of Sjögren’s syndrome in a closed rural community (1997) (184)
Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study (2003) (173)
"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. (2001) (169)
Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. (2007) (168)
Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome (2012) (168)
Sjögren's syndrome in patients with primary biliary cirrhosis (1990) (166)
Genetic polymorphism of IL-12 p40 gene in immune-mediated disease (2000) (160)
Wound healing: immunological aspects. (2006) (158)
Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. (1996) (157)
Predicting the risk for lymphoma development in Sjogren syndrome (2016) (155)
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease. (2002) (152)
Sjögren's Syndrome Associated with HLA-Dw3 (1977) (152)
Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. (2008) (152)
Liver involvement in primary Sjögren's syndrome. (1994) (151)
Genetic differences between primary and secondary sicca syndrome. (1979) (150)
Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis (1999) (149)
Evidence for coxsackievirus infection in primary Sjögren's syndrome. (2004) (149)
Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. (1992) (143)
The management of Sjögren's syndrome (2006) (141)
Methotrexate in primary Sjögren's syndrome. (1996) (140)
Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms. (2012) (138)
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. (2000) (138)
Thyroid disease in Sjögren's syndrome. (1980) (138)
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin (2000) (137)
The spectrum of neurological involvement in Sjögren's syndrome. (1990) (134)
Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. (1999) (134)
Preliminary diagnostic criteria for Sjögren's syndrome. (1986) (133)
Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. (2003) (132)
Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. (2013) (132)
Central nervous system involvement in Sjögren’s syndrome (2004) (131)
Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases (2004) (127)
Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. (2003) (125)
Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. (2006) (124)
The clinical picture of primary Sjögren's syndrome: a retrospective study. (1982) (122)
Prevalence of primary Sjögren's syndrome in an elderly population. (1988) (120)
T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. (1991) (119)
Toll-like Receptor-4 Is Up-Regulated in Hematopoietic Progenitor Cells and Contributes to Increased Apoptosis in Myelodysplastic Syndromes (2007) (118)
Secondary Sjögren's syndrome in rheumatoid arthritis. (1987) (117)
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. (1987) (117)
Sjögren's syndrome. (2019) (116)
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. (1989) (116)
Immune complex glomerulonephritis in sicca syndrome. (1978) (115)
Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen (2006) (114)
Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. (2004) (113)
HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. (1986) (112)
Occult connective tissue diseases mimicking idiopathic interstitial pneumonias (2008) (109)
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome. (2014) (107)
Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome. (1986) (107)
Hypofunction of the stress axis in Sjögren's syndrome. (1998) (106)
Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. (1999) (105)
Systemic Lupus Erythematosus in Greece. Clinical Features, Evolution and Outcome: a Descriptive Analysis of 292 Patients (1993) (104)
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). (2001) (103)
Demonstration of circulating immune complexes in Sjögren's syndrome. (1979) (103)
Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. (1981) (102)
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. (2002) (102)
Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. (2009) (101)
High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. (1983) (101)
Lupus nephritis: treatment with mycophenolate mofetil. (2003) (100)
Vasculitis in primary Sjögren's syndrome. Histologic classification and clinical presentation. (1987) (100)
The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease (2000) (99)
Classification criteria of Sjögren's syndrome. (2014) (98)
Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β2-Glycoprotein I (2011) (97)
HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. (1992) (97)
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study (2011) (97)
Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. A controlled study. (1986) (94)
Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) (2005) (94)
Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease (2016) (94)
Sjogren's Syndrome: Clinical and Immunological Aspects (1987) (93)
Microvascular abnormalities in Sjögren's syndrome: nailfold capillaroscopy. (1999) (92)
Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. (1988) (91)
{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. (2010) (90)
Sjögren's syndrome: why autoimmune epithelitis? (2006) (89)
Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. (2011) (89)
Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. (2001) (87)
Dental and periodontal status of Sjögren's syndrome. (2000) (87)
Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline. (2006) (86)
Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients (2013) (86)
Malignant lymphoma in primary Sjogren's syndrome. (2001) (86)
Functional Expression of a Costimulatory B7.2 (CD86) Protein on Human Salivary Gland Epithelial Cells that Interacts with the CD28 Receptor, but Has Reduced Binding to CTLA41 (2001) (86)
Sjogren's Syndrome (1999) (85)
Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology. (1998) (83)
Lymphoma development in Sjögren's syndrome: novel p53 mutations. (1999) (83)
Long interspersed nuclear element‐1 retroelements are expressed in patients with systemic autoimmune disease and induce type I interferon (2016) (82)
Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study. (1986) (81)
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. (1999) (80)
Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis (2010) (80)
Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients (2015) (79)
Peripheral neuropathies in Sjögren syndrome: a new reappraisal (2010) (79)
Erythema Nodosum: the Underlying Conditions (2000) (79)
CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. (1988) (79)
Diffuse fasciitis with eosinophilia. A clinicopathologic study. (1980) (78)
Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele (2000) (78)
Imaging of thoracic Wegener's granulomatosis: the computed tomographic appearance. (1992) (77)
Echocardiographic identification of cardiac abnormality in scleroderma and related disorders. (1979) (77)
Kidney involvement in primary Sjögren's syndrome. (1986) (77)
Evaluation of tear break-up time, Schirmer's-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. (1989) (76)
Sjögren syndrome (2014) (76)
Headache in systemic lupus erythematosus: a controlled study. (1998) (76)
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. (1993) (75)
Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. (2002) (74)
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. (2000) (74)
The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjögren’s syndrome (autoimmune epithelitis) (2006) (74)
Pulmonary function of nonsmoking patients with systemic lupus erythematosus. (1988) (74)
Sjögren's syndrome. Autoimmune epithelitis. (2000) (72)
Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. (1994) (72)
Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia. (1997) (72)
Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis. (2008) (69)
HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members. (1983) (68)
Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations (2015) (68)
Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance. (1979) (68)
Immune complexes in hepatitis B antigen-associated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay. (1977) (68)
Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations (2016) (68)
Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study (2013) (68)
Lymphoma in Sjogren's syndrome. (1992) (68)
Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases (2016) (68)
A BAFF Receptor His159Tyr Mutation in Sjögren's Syndrome–Related Lymphoproliferation (2015) (67)
Muscle involvement in systemic lupus erythematosus. (1981) (67)
Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. (1980) (67)
Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases. (1976) (66)
Sjögren's syndrome: a forty-year scientific journey. (2014) (66)
Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. (2008) (66)
Sjögren's syndrome in systemic lupus erythematosus. (1990) (66)
Sjögren’s Syndrome: Autoantibodies to Cellular Antigens (2000) (65)
Conventional Therapy of Sjogren’s Syndrome (2007) (65)
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation (2001) (65)
Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren's syndrome. (1998) (65)
Endocrine alterations in primary Sjogren's syndrome: an overview. (2012) (64)
Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. (2008) (64)
Psychiatric Symptoms Associated with Scleroderma (2001) (64)
Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. (1985) (64)
Sjögren's syndrome: Old and new therapeutic targets. (2019) (63)
Cross‐reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein (2005) (63)
Sjögren's syndrome in progressive systemic sclerosis. (1988) (62)
Raynaud's phenomenon in primary Sjögren's syndrome. (1990) (62)
The liver in brucellosis. (2007) (62)
Association of Sjögren's syndrome with HLA-B8. (1976) (62)
Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome (2001) (62)
Minor Salivary Gland Inflammatory Lesions in Sjögren Syndrome: Do They Evolve? (2013) (61)
Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. (1980) (61)
Oesophageal dysfunction in patients with primary Sjögren's syndrome. (1985) (61)
Familial Mediterranean fever associated pyrin mutations in Greece (2003) (60)
Mortality in Sjögren's syndrome. (2008) (58)
Neuroendocrine Dysfunction in Sjögren’s Syndrome (2008) (56)
Xerotrachea and interstitial lung disease in primary Sjogren's syndrome. (1984) (55)
The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. (2004) (55)
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients (2018) (54)
Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. (2009) (54)
Stress, coping strategies and social support in patients with primary Sjögren’s syndrome prior to disease onset: a retrospective case–control study (2008) (53)
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases. (2019) (53)
Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. (1985) (53)
Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity. (2011) (53)
Determinants of pulmonary arterial hypertension in scleroderma. (2007) (53)
Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. (1993) (52)
Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. (1985) (51)
Serological profiles in subgroups of patients with Sjögren's syndrome. (1986) (51)
Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. (1993) (51)
Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms. (2012) (50)
Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods. (1993) (50)
The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods (1998) (49)
Neuropsychiatric abnormalities in primary Sjögren's syndrome. (1989) (49)
New advances in the classification, pathogenesis and treatment of Sjogren's syndrome (2013) (48)
Persistent Viral Infection in Primary Sjogren’s Syndrome: Review and Perspectives (2007) (48)
Sjögren's syndrome: current concepts. (2001) (48)
Unmasking the Anti-La/SSB Response in Sera From Patients With Sjogren’s Syndrome by Specific Blocking of Anti-idiotypic Antibodies to La/SSB Antigenic Determinants (2002) (48)
Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression (2004) (47)
Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. (1989) (47)
Herpes zoster in patients with systemic lupus erythematosus. (1978) (47)
Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. (2015) (46)
HLA-alloantigen associations in Greek patients with Sjögren's syndrome. (1988) (46)
Autoimmune epitheliitis: Sjögren's syndrome. (1994) (45)
Lymphoproliferation in autoimmunity and Sjögren’s syndrome (2003) (45)
Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. (1997) (45)
New developments in Sjögren's syndrome (1989) (45)
Cyclosporin a therapy in patients with primary Sjögren's syndrome: results at one year. (1986) (44)
Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis (2015) (44)
Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. (1983) (43)
Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients (2004) (43)
Pulmonary capillary endothelial dysfunction in early systemic sclerosis. (2001) (43)
Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins (1992) (43)
The forgotten cause of sicca complex; sarcoidosis. (1989) (43)
Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. (2007) (43)
Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. (1993) (42)
Personality structure disturbances and psychiatric manifestations in primary Sjögren's syndrome. (1989) (42)
Elevated IgG4 Serum Levels Among Primary Sjögren's Syndrome Patients: Do They Unmask Underlying IgG4‐Related Disease? (2014) (42)
B-cell activating factor and related genetic variants in lupus related atherosclerosis. (2018) (42)
Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. (1987) (42)
Morbidity, Mortality, and Organ Damage in Patients with Antiphospholipid Syndrome (2012) (41)
Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. (2015) (41)
Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides. (2010) (41)
Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? (1993) (41)
Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory tests for xerostomia. (1989) (41)
Recent Advances in the Treatment of Systemic Sclerosis (2009) (41)
Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. (2011) (40)
Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis. (1996) (40)
Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. (1990) (40)
Primary amyloidosis resembling sicca syndrome. (1979) (39)
Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study. (1997) (39)
Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. (1999) (38)
IgG4-related sialadenitis and Sjögren's syndrome. (2017) (38)
Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. (2006) (38)
Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome. (1987) (38)
Is Sjögren's syndrome a retroviral disease? (2011) (38)
Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. (2000) (37)
Immunopathogenesis of Sjogren's syndrome: "facts and fancy". (1989) (37)
Immunologic factors in the pathogenesis of osteonecrosis. (2004) (37)
Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs). (1999) (37)
Lysozyme determination in parotid saliva from patients with Sjögren's syndrome. (1980) (37)
Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies. (1992) (36)
Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. (1999) (36)
IgG4 Syndrome: Old Disease, New Perspective (2010) (36)
Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study. (2014) (35)
Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. (2011) (34)
B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. (2000) (34)
Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance. (1984) (34)
Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome. (2018) (34)
A link between interferon and augmented plasmin generation in exocrine gland damage in Sjögren's syndrome. (2013) (34)
Autoimmunity and Coxsackievirus Infection in Primary Sjögren's Syndrome (2005) (34)
Antibodies to β2-Glycoprotein-I: Urea Resistance, Binding Specificity, and Association with Thrombosis (1998) (33)
Ultrasonography of salivary glands: an evolving approach for the diagnosis of Sjögren's syndrome (2008) (33)
Autoimmunity and pathophysiology. (2007) (33)
Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies (2018) (33)
Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases (1992) (33)
Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. (2003) (33)
Immunization of patients with Sjögren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial. (1980) (32)
B lymphocyte antigens in sicca syndrome. (1978) (32)
Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome. (1990) (32)
Renal tubular acidosis in primary Sjögren's syndrome (1992) (32)
Neuroendocrine manifestations in Sjögren's syndrome. (2000) (31)
Hypothalamic‐Pituitary‐Adrenal Axis Function in Sjögren's Syndrome (2006) (31)
A comprehensive evaluation for the treatment of lupus nephritis. (2017) (31)
MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome (2017) (31)
Detection of anti-interferon antibodies in systemic lupus erythematosus. (1983) (31)
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases (2021) (30)
c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome. (1992) (30)
Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development (2020) (30)
The gastrointestinal involvement in primary Sjögren's syndrome. (1986) (30)
Clinical implications of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis. (1988) (30)
Factors related to the presence of autoantibodies in patients with chronic mental disorders (1990) (30)
Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes. (2011) (30)
Primary versus Secondary Sjögren Syndrome: Is It Time To Reconsider These Terms? (2019) (29)
Sjögren's syndrome revisited: autoimmune epithelitis. (1996) (29)
Vasculitis in primary Sjögren’s syndrome (1996) (29)
Sjögren's syndrome. (2007) (29)
Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome. (2002) (29)
Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders--a paraneoplastic lymphocytic vasculitis of the skin. (1995) (28)
Recent advances in the management of ocular complications of sjögren’s syndrome (2005) (28)
Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen (2000) (28)
Serum isoamylases in patients with autoimmune rheumatic diseases. (1984) (28)
Oral and sialochemical findings in patients with autoimmune rheumatic disease. (1987) (27)
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease (2015) (27)
Neuroendocrine Manifestations in Sjögren's Syndrome: Relation to the Neurobiology of Stress (2000) (26)
Systemic lupus erythematosus : clinical features in patients with a disease duration of over 10 years , first evaluation 1 (1999) (26)
Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study (2018) (26)
In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases. (1976) (26)
Hypokalaemic paralysis as the presenting manifestation of primary Sjögren's syndrome. (1994) (26)
ogren's Syndrome (2014) (26)
Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. (1998) (26)
2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation. (2002) (26)
Labial salivary gland immunopathology in Sjögren's syndrome. (1986) (26)
Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome (1990) (25)
A major Sm epitope anchored to sequential oligopeptide carriers is a suitable antigenic substrate to detect anti-Sm antibodies. (1998) (25)
Nandrolone decanoate (deca-durabolin) in primary Sjögren's syndrome: a double blind pilot study. (1988) (25)
Lymphoid Malignancy and Monoclonal Proteins (1987) (25)
The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study. (2012) (25)
Lupus nephritis: current issues (2003) (25)
Estrogen receptor alpha gene polymorphism and systemic lupus erythematosus: a possible risk? (2005) (25)
Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma. (1991) (25)
The oral mucosa: A barrier site participating in tissue-specific and systemic immunity. (2018) (24)
Middle ear function in patients with juvenile chronic arthritis. (1990) (24)
Soluble interleukin-2 receptors and autoantibodies in the serum of healthy elderly individuals. (1990) (24)
Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up (1990) (24)
Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. (2003) (24)
Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus. (1996) (24)
2 Glycoprotein I ( 2 GPI ) binds platelet factor 4 ( PF 4 ) : implications for the pathogenesis of antiphospholipid syndrome (2010) (23)
Transient hemophagocytosis in Brucella melitensis infection. (1984) (23)
The salivary gland epithelial cells of patients with primary Sjögren's syndrome manifest significantly reduced responsiveness to 17β-estradiol. (2012) (23)
Impaired Clearance of Early Apoptotic Cells Mediated by Inhibitory IgG Antibodies in Patients with Primary Sjögren's Syndrome (2014) (23)
Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations. (2020) (23)
B-Cell Epitopes of Intracellular Autoantigens: Myth and Reality (2000) (23)
Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells. (2006) (22)
Immunoreactivity and conformation of the P-P-G-M-R-P-P repetitive epitope of the Sm autoantigen. (2009) (22)
Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus. (2002) (22)
Slow viruses and the immune system in the pathogenesis of local tissue damage in Sjögren's syndrome. (1992) (22)
Immunologic Abnormalities in Sjögren’s Syndrome (1987) (22)
Mixed Cryoglobulinemia in HIV-1 Infection: The Role of HIV-1 (1999) (22)
Letter: Sjögren's syndrome with light chain myeloma. (1975) (21)
A Novel B7-2 (CD86) Splice Variant with a Putative Negative Regulatory Role1 (2008) (21)
Identification of HIV-specific oligoclonal immunoglobulins in serum of carriers of HIV antibody. (1988) (21)
Monoclonal and oligoclonal immunoglobulins in the serum of patients with B-chronic lymphocytic leukemia. (1988) (21)
Therapy of Sjögren’s syndrome (2009) (21)
Clinical features of Sjögren's syndrome. (1990) (21)
Sjögren’s Syndrome: The Clinical Spectrum of Male Patients (2020) (20)
Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis. (2018) (20)
Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study. (1990) (20)
Increased Prevalence of Antibodies to Thyroid Peroxidase in Dry Eyes and Mouth Syndrome or Sicca Asthenia Polyalgia Syndrome (2009) (20)
Hand radiographic changes in patients with primary and secondary Sjögren's syndrome. (1986) (20)
Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19 (2020) (20)
IgG4-related disease: a rheumatologist's perspective. (2014) (20)
A new helicoid-type sequential oligopeptide carrier (SOC(n)) for developing potent antigens and immunogens. (1999) (20)
Management of Hypereosinophilic Syndrome: A Prospective Study in the Era of Molecular Genetics (2007) (20)
West Nile Virus infection triggering autoimmune encephalitis: Pathophysiological and therapeutic implications. (2019) (20)
IL-2 and IL-10 Production by Human CD4+T Cells Is Differentially Regulated by p38: Mode of Stimulation-Dependent Regulation of IL-2 (2004) (20)
Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis (2004) (19)
Rheumatoid arthritis in Greece: clinical, serological and genetic considerations. (1995) (19)
Neurologic involvement in primary Sjögren's syndrome: a preliminary report. (1989) (19)
D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors. (1991) (19)
Low-dosage heparin in rapidly progressive glomerulonephritis. (1976) (19)
Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptides. (1999) (19)
Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera. (1988) (19)
Sjögren's syndrome association with HLA-Dw3. (1977) (19)
Pulmonary function of nonsmoking patients with rheumatoid arthritis in the presence and absence of secondary Sjögren's syndrome, a controlled study. (1988) (18)
Hemorrhagic fever with renal syndrome in an endemic area of Greece. (1992) (18)
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study (2010) (18)
Glucocorticoid Receptor, Nuclear Factor κB, Activator Protein-1 and C-Jun N-Terminal Kinase in Systemic Lupus Erythematosus Patients (2006) (18)
The uncertain role of immunosuppressive agents in Sjögren's syndrome. (1997) (18)
Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity (2019) (18)
Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome. (2015) (17)
Monarthric arthritis caused by metastatic breast carcinoma. Value of cytologic study of synovial fluid. (1975) (17)
Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells. (2009) (17)
Antiphospholipid Syndrome: Clinical and Therapeutic Aspects (1994) (17)
Oestrogen receptors in cultured epithelial cells from salivary glands of Sjogren's syndrome patients. (2003) (16)
Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores. (2016) (16)
Rheumatoid arthritis in the elderly (1999) (16)
Impaired elastic properties of ascending aorta in patients with giant cell arteritis (2004) (16)
Sicca-like syndrome in type V hyperlipoproteinemia. (1980) (16)
Brief report: adrenal autoimmunity in primary Sjögren's syndrome. (2012) (16)
Recognition of subsets of the mammalian A/B-type core heterogeneous nuclear ribonucleoprotein polypeptides by novel autoantibodies. (1996) (16)
Cytokines in Sjögren's syndrome. (1995) (16)
Serum C-reactive protein in primary Sjögren's syndrome. (1983) (16)
HLA-class II alleles and C4 null genes in Greeks with systemic lupus erythematosus. (1995) (15)
Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome. (2017) (15)
Lumping or splitting autoimmune rheumatic disorders? Lessons from Sjögren's syndrome. (1998) (15)
Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA. (1993) (15)
Sjögren's syndrome and the gut. (1989) (15)
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review (2021) (15)
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. (2020) (15)
Antibodies to EYRKK vesicular stomatitis virus‐related peptide account only for a minority of anti‐Ro60kD antibodies (1994) (14)
Unusual eye manifestations in systemic lupus erythematosus patients (1989) (14)
Circulating antibodies to prothymosin α in systemic lupus erythematosus (1989) (14)
HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. (1999) (14)
No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs). (2000) (14)
Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. (2008) (14)
Determination of anti-ds-DNA antibodies by three different methods: Comparison of sensitivity, specificity and correlation with lupus activity index (LAI) (1990) (14)
Sialochemistry of patients with autoimmune rheumatic disease with and without histological manifestations of Sjögren's syndrome. (1985) (14)
No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage (2008) (14)
Monoclonal immunoglobulins in the serum of patients with primary Sjögren's syndrome. (1988) (14)
Histologic lesion in labial salivary glands of patients with systemic lupus erythematosus. (1991) (14)
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine (2021) (13)
Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study. (2003) (13)
Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations (2016) (13)
Longterm Followup After Tapering Mycophenolate Mofetil During Maintenance Treatment for Proliferative Lupus Nephritis (2011) (13)
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score. (2021) (13)
Sjögren's syndrome: an oligo-monoclonal B cell process. (1990) (13)
Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? (2004) (13)
Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome. (2016) (13)
Immunopathology of Sjogren's Syndrome: More Questions than Answers (1993) (13)
Chest CT findings in patients with inflammatory myopathy and Jo1 antibodies. (2008) (12)
Type I interferonopathy in a young adult. (2017) (12)
Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal process. (1986) (12)
Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study. (2017) (12)
Antimalarials in Sjögren's syndrome--the Greek experience. (1996) (12)
Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. (2004) (12)
Tongue Atrophy in Sjögren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands? (2018) (11)
Sicca syndrome following immune checkpoint inhibition. (2020) (11)
Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome (2018) (11)
Cyclosporin-associated nephropathy in patients with autoimmune diseases (1988) (11)
Lung involvement in Sjögren's syndrome (1999) (11)
Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis ? (1990) (11)
Osteoarticular manifestations of antiphospholipid syndrome. (2006) (11)
Rituximab therapy in Greek patients with rheumatoid arthritis (2008) (10)
Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms. (2018) (10)
Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge. (2007) (10)
Specific antigen and antibody to mycobacterium leprae in the cryoprecipitate of a patient with lucio phenomenon (2004) (10)
Mixed cryoglobulinemia is associated with increased risk for death, or neoplasia in HIV‐1 infection (2001) (10)
Psychological characteristics of systemic sclerosis patients and their correlation with major organ involvement and disease activity. (2013) (10)
LIPOID NEPHROSIS AND FOCAL GLOMERULOSCLEROSIS IN A PATIENT WITH POLYMYOSITIS (1975) (10)
Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective? (2018) (10)
Renal involvement in antiphospholipid syndrome. (2001) (10)
Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma. (1994) (9)
Lack of HLA-antigen association in Greek rheumatoid arthritis patients (2004) (9)
Detection of human-specific anti-la(SSB) antibodies in patients with rheumatoid arthritis. (1995) (9)
Clinical significance of autoantibodies to Ro/SSA and La/SSB (1996) (9)
Incidence and Prevalence of Major Central Nervous System (CNS) Involvement in Systemic Lupus Erythematosus (SLE): A 3 Year Prospective Evaluation and Clinical Correlations in 456 Patients (S08.004) (2012) (9)
Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. (1992) (8)
Lactate levels in brucella arthritis (2004) (8)
Is mizoribine a new therapeutic agent for Sjögren's syndrome? (2008) (8)
Linear epitopes of two different autoantigens-La/SSB and myelin basic protein--with a high degree of molecular similarity, cause different humoral immune responses. (2003) (8)
Rheumatoid arthritis in south-east Europe. (1992) (8)
Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders (2021) (7)
Comparative qualitative and quantitative analysis of scleroderma (systemic sclerosis) serologic immunoassays. (2008) (7)
Circulating antibodies to prothymosin alpha in systemic lupus erythematosus. (1989) (7)
Epitope specificity of anti-La antibodies from patients with Sjögren's syndrome. (1989) (6)
Treatment of Sjögren’s Syndrome (1987) (6)
Dapsone: an old drug effective for subacute cutaneous lupus erythematosus. (2019) (6)
IgG4‐Related Orbital Disease Presenting With Unilateral Eyelid Swelling (2016) (6)
Systemic sclerosis (scleroderma) (2001) (6)
CT evaluation of mediastinal lymph nodes in primary Sjögren syndrome. (1988) (6)
Atherosclerosis in SLE: a potential role for serum parathormone levels (2020) (6)
A diepitopic sequential oligopeptide carrier (SOCn) as mimic of the Sm autoantigen: synthesis, conformation and biological assays (2001) (6)
New insights into the physiopathology of primary Sjögren's syndrome. (1990) (6)
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome. (2021) (6)
Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon. (1985) (6)
Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis (2017) (6)
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome (2021) (6)
Polyarteritis nodosa associated with cholangiocarcinoma (1998) (6)
Linear IgA dermatosis in a patient with primary Sjogren's syndrome. (2013) (6)
Antiendothelial cell antibodies in patients with coronary artery ectasia (2010) (6)
The position of the LysN epsilon H2-grafted antigens along the sequential oligopeptide carrier, Ac-(Aib-Lys-Aib-Gly)n (SOCn-II), influences the antibody recognition: application to the Sm main autoimmune epitope. (2000) (5)
Medications, Therapeutic Modalities, and Regimens Used in the Management of Rheumatic Diseases (2020) (5)
Rare rheumatic disorders. A. Behçet's disease. (1993) (5)
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity. (2020) (5)
The Respiratory System in Sjögren’s Syndrome (1987) (5)
Lactic acid levels in cerebrospinal fluid from patients with systemic lupus erythematosus. (1979) (5)
Atrophie blanche. Clinical diagnosis and treatment. (1991) (5)
Prevalence of Non-Organ-Specific Autoantibodies in Pregnant and Non-Pregnant Healthy Women (1992) (5)
Sjogren's syndrome. (2013) (5)
HLA alloantigens in Greek patients with systemic lupus erythematosus. (1990) (5)
Sjögren-like Disease and Silicone Implants A Greek Experience. (1998) (5)
Immunologic abnormalities in idiopathic Raynaud's phenomenon. (1983) (5)
IgG4‐Related Nodular Lung Lesion (2017) (5)
Absence of somatic MYD88 L265P mutations in patients with primary Sjogren’s syndrome (2013) (5)
Anticentromere (ACA)-positive Sjӧgren's syndrome: a disease entity? (2013) (5)
Autoimmune rheumatic diseases: One or many diseases? (2021) (5)
OP0079 Salivary Gland Epithelial Cells (SGECS) Promote the Differentiation of B Cells (2013) (5)
Periodic fevers in adult Greeks: clinical and molecular presentation. (2014) (5)
Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis. (2016) (5)
Sjögren’s Syndrome: From Polyclonal B Cell Activation to Monoclonal B Cell Proliferation (1994) (5)
Combined seronegativity in Sjögren's syndrome. (2021) (5)
Sjögren's syndrome: a human model of autoimmunity and malignancy. (1988) (4)
Demographics, clinical characteristics and predictive factors for total knee or hip replacement in patients with rheumatoid arthritis in Greece. (2013) (4)
Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma? (2021) (4)
Histocompatibility antigen combinations in rheumatoid arthritis. (1983) (4)
Non-organ specific autoantibodies against cellular components in HIV-1 infected individuals. (1997) (4)
HLA class II sequence polymorphism and susceptibility to rheumatoid arthritis in greece (1991) (4)
Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies. (1990) (4)
An overlap of diffuse fasciitis with eosinophilia and scleroderma (2004) (4)
Pyruvate dehydrogenase as an antigen to detect antimitochondrial antibodies. (1990) (4)
Clinical Significance of Higher Cutoffs for Myositis Autoantibody Positivity Using the Euroimmun Research Line Blot: Comment on the Article by Mecoli et al (2020) (4)
Possible viral implication in the pathogenesis of Sjögren's syndrome. (1992) (4)
Systemic lupus erythematosus and tracheal stenosis. (1999) (4)
New developments in Sjögren's syndrome. (1989) (4)
Immunology and Rheumatology in Questions (2021) (4)
Autoimmune diseases: role of coxsackieviruses in their pathogenesis. (2004) (3)
Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome (2022) (3)
Monoclonal anti-cross-reactive idiotype antibodies as possible probes for lymphoproliferation in primary Sjögren's syndrome. (1989) (3)
Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al. (2001) (3)
Chapter 35 – Sjögren’s Syndrome (2014) (3)
Facial Papular Lesions in Granulomatosis With Polyangiitis (2020) (3)
Efficacy and safety of the fully human anti-tumour necrosis factor a monoclonal antibody adalimumab ( D 2 E 7 ) in DMARD refractory patients with rheumatoid arthritis : a 12 week , phase II study (2003) (3)
Association of DR4 related RFLP bands and RA in Greeks. (1990) (3)
Sjögren's syndrome therapy: future directions. (1997) (3)
Sjögren’s Syndrome (1987) (3)
Epitopes and complementary epitopes of autoantigens: candidate probes to study and modulate the autoimmune response. (2002) (3)
Salivary gland imaging techniques for the diagnosis of Sjögren’s syndrome (2009) (3)
Sjogren’s Syndrome, a Model to Study Autoimmunity and Malignancy (1990) (3)
THU0204 ASSOCIATION OF LILRA3 GENE WITH LYMPHOMAGENESIS RISK IN YOUNG SS PATIENTS (2019) (3)
Pathogenetic Aspects of Primary Sjögren’s Syndrome (2011) (3)
Protease inhibitor phenotypes and pulmonary disease in patients with Sjögren's syndrome. (1981) (3)
Oesophageal dysfunction inpatients withprimary Sjogren' s syndrome (1985) (3)
The PPGMRPP repetitive epitope of the Sm autoantigen: Antigenic specificity induced by conformational changes. Application of the Sequential Oligopeptide Carriers (SOCs) (2006) (3)
Treatment of dry eyes in Sjögren's syndrome: the role of autologous blood serum (2013) (3)
THU0223 CHRONIC ADRENERGIC STIMULATION OF MINOR SALIVARY GLANDS OF PATIENTSWITH PRIMARY SJÖGREN’S DRIVES ER STRESS AND ACTIVATION OF THE UNFOLDED PROTEIN RESPONSE (2019) (2)
Rheumatoid Arthritis in Southeastern Europe (1992) (2)
Evolution of one systemic rheumatic disease into another: scleroderma evolving to eosinophilic fasciitis with myositis. (2019) (2)
Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies (2022) (2)
FRI0222 ANALYSIS OF CLINICAL AND SEROLOGICAL PICTURE OF PATIENTS WITH PRIMARY SJöGREN’S SYNDROMEAND AN EARLY DISEASE ONSET AT AGE BEFORE 35 YEARS (2019) (2)
Nephro-Urological Involvement (2011) (2)
Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Mixed Connective Tissue Disease (2018) (2)
Evolution from one autoimmune disorder to another. Epitope spreading? (2018) (2)
Adrenal Autoimmunity in Primary Sjogren's Syndrome (2012) (2)
Sjögren's syndrome: disease activity indexes! Do they make us better clinicians or technicians? (2018) (2)
Relapsing polychondritis: a diagnosis not to be missed. (2018) (2)
THU0228 EXPRESSION OF APOBEC FAMILY MEMBERS AS REGULATORS OF ENDOGENOUS RETROELEMENTS AND MALIGNANCY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND SJÖGREN’S SYNDROME (2019) (2)
[HLA antigens in patients with Sjögren's syndrome]. (1988) (2)
Lesson of the month 2: Fever, arthralgias and hyperkeratotic, scaling and fissuring eruptions of the hands. (2019) (2)
Inability of peripheral blood leukocytes from systemic lupus erythematosus patients to produce interferons in vitro. (1983) (2)
Chest Pain in a 39-Year-Old Man: What Could Be the Underlying Cause? (2016) (2)
Systemic Autoimmune Manifestations: When Should Underlying Thyroid Autoimmunity be Considered? (2006) (2)
Renal tubular abnormalities in a patient with lupus nephritis. (1976) (2)
Etiology and Pathogenesis of Sjögren's Syndrome with Special Emphasis on the Salivary Glands (2011) (2)
Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient. (2018) (2)
Risk of Lymphoma in Autoimmune Rheumatic Conditions—Reply (2006) (2)
Sjogren's syndrome patients: Hostility features and psychiatric symptomatology (1989) (2)
Are primary and secondary Sjogren's syndromes different diseases? «Clinical, serologic, immunogenetic and immunopathologic aspects» (1987) (2)
COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases (2022) (2)
Predicting autoimmune congenital heart block: is it feasible and how? (2007) (1)
THU0137 Effectiveness and Adverse Reactions of Long-Term Use of Biologic Agents in Patients with Rheumatoid Arthritis: A Retrospective Study (2013) (1)
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers (2021) (1)
Marcos Tsacopoulos, MD, PhD, 1939–2002 (2003) (1)
Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature (2021) (1)
Rheumatoid arthritis in greece (2004) (1)
Sjögren's Syndrome — Autoimmune EpithelitisRole of Coxsackieviruses in Pathogenesis (2004) (1)
THU0325 Elevated IgG4 Serum Levels Among Primary Sjogren’s Syndrome Patients: Do they Unmask Underlying IgG4-Related Disease? (2013) (1)
Outcomeofpregnancy inpatients withautoimmune rheumatic disease before thedisease onset (1988) (1)
Effect of nandrolone decanoate (Deca-Durabolin) on the disease activity of female patients with systemic lupus erythematosus (1994) (1)
+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications (2021) (1)
Sjögren's Syndrome and the Lung (2004) (1)
Human infection with Dirofilaria (Nochtiella) conjunctivae in Greece. (1969) (1)
Demonstration andidentification ofmonoclonal proteins intheurine ofpatients withSjogren's syndrome (1985) (1)
CHAPTER 31 – Sjögren Syndrome (2006) (1)
Myositis autoantibodies: Clinical significance of higher cut- offs using the Euroimmun Research Line Blot. (2020) (1)
Highprevalence ofanti-cardiolipin andother autoantibodies inahealthy elderly population (1987) (1)
[Gougerot-Sjögren syndrome: the viruses in the box of the accused]. (1994) (1)
Inflammatory Arthritides (2020) (1)
Outcome of pregnancies in patients with antibodies to Ro(SSA) cellular antigen. (1987) (1)
Rheumatology in Questions (2018) (1)
THROMBOSIS AND HEMOSTASIS 2 Glycoprotein I ( 2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome (2010) (1)
Sjögren's syndrome revisited. (1995) (1)
Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patients (2004) (1)
AB0181 ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) OF THE BAFF GENE AND FATIGUE IN PRIMARY SJöGREN’S SYNDROME (2019) (1)
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk. (2021) (1)
Mentoring in medicine (2019) (1)
Immunologic Similarities and Differences Between Systemic Lupus Erythematosus and Sjögren’s Syndrome (1987) (1)
B-cell Epitopes of Sjögren’s Syndrome-Related Autoantigens Ro/SSA and La/SSB (2011) (1)
Livedoid Vasculopathy (2017) (1)
Rheumatic Disorders Associated with Metabolic, Endocrine, and Hematological Diseases (2020) (1)
The third international symposium on Sjogren's syndrome. (1992) (1)
Bone, Cartilage, and Soft Tissue Disorders (2020) (1)
Rheumatology in Greece: pros and cons (2020) (1)
Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects (2020) (1)
Risk of lymphoma in autoimmune rheumatic conditions. Authors' reply (2006) (1)
Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations (2022) (0)
FRI0297 CLINICAL FEATURES, TREATMENT MODALITIES AND RELAPSE RATES IN GREEK PATIENTS WITH RETROPERITONEAL FIBROSIS (2019) (0)
Letter: Treatment failure with nitroglycerin. (1975) (0)
Cl in ic ian ’ s Corner Systemic Activity at Diagnosis of Sjögren ’ s : A Key Prognostic Marker (2015) (0)
Systemic Sclerosis (2020) (0)
Microinvasion of lymph nodes from papillary thyroid cancer in a patient with systemic lupus erythematosus under immunosuppression (2020) (0)
Sjögren's syndrome or autoimmune epithelitis? (1996) (0)
Medical education in Greece: Necessary reforms need to be re-considered (2020) (0)
Production of potent specific antigens and effective immunogens using sequential oligopeptide carriers (SOC n ) (2002) (0)
Sialochemistry ofpatients withautoimmune rheumatic disease withandwithout histological manifestations ofSjiogren's syndrome (1985) (0)
Immunogenetic associations in patients with primary Sjogren's syndrome (pSS), SLE with co-existing Sjogren's syndrome (SLE-SS) and SLE without Sjogren's syndrome (SLE-noSS) (2004) (0)
Sjögren’s Syndrome: Role of Viruses and Viral-Like Sequences (2015) (0)
A study of the serum immunoglobulins af er cholera vaccination. (1971) (0)
Preliminary Pages / Contents (2000) (0)
Sjeogren's syndrom (2013) (0)
Lessons of the month: Reemergence of rheumatic fever after a systemic streptococcal A infection: The role of cardiac MRI on the diagnosis of subclinical rheumatic carditis. (2020) (0)
FRI0161 PHENOTYPIC DIFFERENCES BETWEEN SJÖGREN’S SYNDROME PATIENTS WITH LOW AND HIGH-GRADE INFLAMMATION BASED ON SALIVARY GLAND FOCUS SCORE (2020) (0)
MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome (2017) (0)
The "Distinguished" Physician-Scientist: Is a single bibliometric index sufficient for distinction? (2020) (0)
Corticosteroid therapy for rheumatoid arthritis masking double ectopic parathyroid adenomas. (2020) (0)
In memorial to Pierre Youinnou. (2022) (0)
sclerosis . interferon in the treatment of systemic Safety and efficacy of recombinant gamma and (0)
Basic Immunology (2020) (0)
Systemic sclerosis ( scleroderma ) Author : Doctor (2004) (0)
Vasculitis and Sjögren’s Syndrome (2011) (0)
NeutraSal ® is clinically proven to help restore the oral environment 2 FOR PATIENTS WITH SJÖGREN ’ S SYNDROME 90 % OF PATIENTS REPORTED IMPROVEMENT IN SWALLOWING (2017) (0)
Autoimmunity: pathogenetic aspects. (1996) (0)
Safety and efficacy of recombinant y interferon in the treatment of systemic sclerosis (0)
2nd Iberoamerican Congress on Neuroimmunomodulation. Madrid, April 9–22, 2007 (2007) (0)
This information is current as Putative Negative Regulatory Role A Novel B 7-2 ( CD 86 ) Splice Variant with a and (2008) (0)
Chapter 12 – Sjögren’s Syndrome (2017) (0)
Ask the experts. (2001) (0)
THU0012 BAFF Genetic Variants in Lymphomagenesis Associated with Sjogren’s Syndrome (2013) (0)
The Skin, the Eyes, and the Ears in Rheumatic Diseases (2020) (0)
[Prospects of studies on Sjögren's syndrome]. (1988) (0)
Contents, Vol. 55, 1989 (1989) (0)
Vasculitides and Related Diseases (2020) (0)
Immunological studies of synthetic peptides related to the Sjögren’s Syndrome (1993) (0)
Sixth Eular Workshop on Rheumatology Research (1986) (0)
FRI0149 THE CLINICAL FEATURES OF SJÖGREN’S SYNDROME PATIENTS WITH EARLY AND LATE DISEASE ONSET (2020) (0)
I-06 Long interspersed nuclear element-1 retroelements are expressed in patients with systemic lupus erythematosus and primary SJOGREN’S syndrome and induce type I interferon (2016) (0)
Comprar Sjögren’s Syndrome | Moutsopoulos, Haralampos M. | 9780857299468 | Springer (2011) (0)
TNF blockade in orphan rheumatic diseases (2007) (0)
Rheumatic Manifestations: A Compilation (2020) (0)
Clinical aspects of autoimmunity (2004) (0)
MicroRNA (miRNA) molecules as candidate regulators of Ro/SSA and La/SSB mRNA expression in Sjögren's syndrome (2012) (0)
Rapidly progressive lung disease in a patient with signs of clinically amyopathic dermatomyositis. (2017) (0)
Cytotoxics or biologicals in the treatment of Sjögren’s syndrome? (2012) (0)
DQA1∗0501 involvement in susceptibility to primary Sjogren's syndrome: A study of Jewish and Greek patients (1992) (0)
Expression of chitinase-like proteins in inflamed tissues of Sjögren’s Syndrome (SS) patients (135.6) (2010) (0)
Renal Pathology After Low Dose Cyclosporine (CyA) in Patients with Primary Sjogren’s Syndrome (1989) (0)
Monoclonal processinprimary Sjogren's syndromeand cross-reactive idiotype associated withrheumatoid factor (1990) (0)
Assessment oftheEuropean classification criteria forSjogren's syndrome inaseries ofclinically defined cases: results ofaprospective multicentre study (1996) (0)
Dr. Laskari, et al reply (2011) (0)
TLR3-mediated induction of Ro/SSA and La/SSB mRNA expression in salivary gland epithelial cells (2012) (0)
Patients’ organizations (2013) (0)
Cyclosporin A (CyA)inprimary Sjogren's syndrome: adouble blind study (1986) (0)
Keratoderma Blenorrhagica (2018) (0)
Sepsis and Meningitis Due to Capnocytophaga cynodegmi after Splenectomy (2005) (0)
Clinico-pathological conference. Lepromatous leprosy. (1997) (0)
Subject Index, Vol. 53, 1988 (1988) (0)
Inflammatory Muscle Disease (2020) (0)
Systemic Lupus Erythematosus, Mixed Connective Tissue Disease and Antiphospholipid Syndrome (2020) (0)
Sjögren’s Syndrome, IgG 4 -Related Disorders (2018) (0)
Interview with Haralampos M. Moutsopoulos. What's going to happen as far as the natural history of Sjögren's syndrome is concerned?. Interview by Pierre Youinou. (1994) (0)
Sjögren’s Syndrome, IgG4-Related Disorders (2020) (0)
Top Stories 7 Clinician ’ s Corner – Nail Capillaroscopy in SS 9 New Partnerships for 2010 SSF Student Fellowships 15 Patient Education – Anti-Inflammatory Diet (2010) (0)
Obituary for Joachim Robert Kalden (2021) (0)
干燥综合征分类标准：美国-欧洲合意小组制定的欧洲标准修订版 (2004) (0)
[Anti-endothelium antibodies]. (1991) (0)
The PPGMRPP repetitive epitope of the Sm autoantigen: Antigenic specificity induced by conformational changes. Application of the Sequential Oligopeptide Carriers (SOCs) (1997) (0)
Antiphospholipid syndrome Author : Doctor (2004) (0)
Antisynthetase syndrome Author : Doctor (2005) (0)
HLA-DRexpression bylabial minorsalivary gland tissues inSjogren's syndrome (1986) (0)
aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases (2010) (0)
[Immunopathology of the salivary glands of the lips in Sjögren's syndrome]. (1988) (0)
Contents, Vol. 101, 1993 (1993) (0)
07.08 Contribution of mthfr gene polymorphisms in primary sjögren’s syndrome related lymphomagenesis (2017) (0)
Professor Norman Talal 1934–2015 (2015) (0)
A tribute to Norman Talal. (2015) (0)
Sjögren’s Syndrome: The Significance of Epithelial Cells (1999) (0)
SSF Clinical Practice Guidelines for Caries Prevention are Here ! (2016) (0)
07.13 A case of sting-associated vasculopathy with onset in infancy (savi) in a young adult male with a novel tmem173 gene mutation (2017) (0)
Current Treatment of Extraglandular Manifestations with Disease-Modifying and Immunosuppressive Agents (2011) (0)
AB0514 PARATHORMONE BUT NOT VITAMIN D SERUM LEVELS ARE ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (2019) (0)
An unusual presentation of giant cell arteritis in a middle-aged woman. (2020) (0)
Passion for Excellence: My Lifelong Journey into Medicine and Public Service (2022) (0)
Epitope mapping of the 60-kDa Ro/SSA protein: Specific recognition of the main antigenic determinants from the autoimmune rheumatic diseases autoantibodies (1995) (0)
07.11 Contribution of mthfr gene variants in lupus related subclinical atherosclerosis (2017) (0)
Conformational study of the complementary peptide to a B-cell epitope of the La/SSB autoantigen (2001) (0)
Correspondence on ‘Jan Gösta Waldenström and rheumatology’ (2020) (0)
OP0083 RO52/TRIM21 Expression in Salivary Gland Epithelial Cells (SGECS) is Upregulated by TLR3-Signaling (2013) (0)
Pauci-immune crescentic glomerulonephritis in a patient with B-lymphocyte poly/autoreactivity. (2018) (0)
Immunopathogenesis of Sjögren's syndrome. (1988) (0)
Slowviruses andtheimmunesysteminthe pathogenesis oflocal tissue damageinSjogren's syndrome (1992) (0)
Author and Subject Index (2000) (0)
THU0294 THE DIFFERENCES IN THE CLINICAL SPECTRUM OF CRYOGLOBULINEMIC VASCULITIS BETWEEN SJÖGREN’S SYNDROME AND HCV HEPATITIS (2020) (0)
Obstetric andgynaecological profile inpatients withprimarySjogren's syndrome (2011) (0)
Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: The impact of BAFF genetic variations. (2022) (0)
24 - Sjögren's Syndrome — Autoimmune Epithelitis: Role of Coxsackieviruses in Pathogenesis (2004) (0)
The Professionals ’ Resource on Sjögren ’ s Syndrome First Genetic Associations Established for Sjögren ’ s (2014) (0)
Autoimmune phenomena in myelodysplastic syndromes: A four year prospective study (2004) (0)
[Autoimmunity, a concept of variable geometry]. (1990) (0)
Treatment of B-Cell Lymphoma (2011) (0)
CHAPTER 14Nervous System Involvement in Sjogren's Syndrome (2004) (0)
Chapter 19 Renal Involvement in Sjögren Syndrome (2007) (0)
Obituary for Efstratios (Stratis) Avrameas (2022) (0)
patients . marker for rheumatoid arthritis in Greek Examination of HLA-DR 4 as a severity (2004) (0)
Drs. Mavragani and Moutsopoulos reply (2019) (0)
OP0096 THE DIFFERENCES BETWEEN SJÖGREN’S SYNDROME PATIENTS WITH COMBINED SERONEGATIVITY AND ANTI-RO/SSA SEROPOSITIVITY (2020) (0)
A case of antisynthetase syndrome (2020) (0)
P413 - HLA associations in patients with late onset rheumatoid arthritis (1996) (0)
Mediterranean Symposium of rheumatology (1985) (0)
Supplementary figures are available at Rheumatology Online. (2005) (0)
Contents, Vol. 53, 1988 (1988) (0)
REGULATORS OF RO/SSA AND LA/SSB MRNA EXPRESSION IN SJÖGREN’S SYNDROME (2012) (0)
Subject Index, Vol. 55, 1989 (2004) (0)
Delayed hypersensitivity to toxoplasmin in relation to age and sex. (1970) (0)
CHITINASES IN SALIVARY GLANDS AND CIRCULATION IN SJÖGREN’S SYNDROME - MACROPHAGE HARBINGERS OF DISEASE SEVERITY (2011) (0)
Cardiac Magnetic Resonance Imaging Detects Long-Term Fibrotic Changes in Patients with Primary Eosinophilic Disorders: A Cross-Sectional Study (2008) (0)
Interstitial lung pathology: should we test for autoantibodies to cellular antigens? (2019) (0)
IX Eular Workshop for Rheumatology Research (1989) (0)
Sjögren ' s syndrome Author : Doctor (2004) (0)
Autoinflammatory Syndromes (2020) (0)
Treatment Failure With Nitroglycerin (1975) (0)
Interstitial Lung Disease in Sjogrens Syndrome (2010) (0)
Sjögren ' s syndrome . pathogenesis of local tissue damage in Slow viruses and the immune system in the (0)
Nephroloqy Dialysis Transplantation Hypokalaemic paralysis as the presenting manifestation of primary Sjogren ' s syndrome (2005) (0)
HLA DR alloantigens indifferent subsets ofpatients withSj6gren's syndrome andinfamily members (1983) (0)
Molecular analysis of HLA class II genes in primary sjo¨gren's syndrome (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Haralampos Moutsopoulos?

Haralampos Moutsopoulos is affiliated with the following schools:

Haralampos Moutsopoulos's Academic­Influence.com Rankings

Why Is Haralampos Moutsopoulos Influential?

Haralampos Moutsopoulos's Published Works

Published Works

What Schools Are Affiliated With Haralampos Moutsopoulos?

Haralampos Moutsopoulos's AcademicInfluence.com Rankings